Fonar has retained an investment banker to assess its MRI operations, the Melville, NY, company announced on March 3. While Fonar executives aren’t providing any details about the firm’s intentions, the company did say that it plans to make
Fonar has retained an investment banker to assess its MRI operations, the Melville, NY, company announced on March 3. While Fonar executives arent providing any details about the firms intentions, the company did say that it plans to make the investment community aware of the new MRI technologies amassed by Fonar from its recent heavy investment in R&D that are expected to enhance shareholder value.
Its unclear whether that awareness could translate into a divestiture of the MRI business. Fonar for the last several years has been attempting a comeback in MRI, but the vendor has been stymied by a lack of market interest in its new line of Quad scanners. For the companys most recent financial period, Fonar recorded only $602,000 in product sales (SCAN 3/3/99).
On the other hand, Fonar has been successful in making acquisitions to increase its healthcare services business, which has been the engine behind the firms revenue growth. The company said its retention of an investment banker will help the firm evaluate prospective acquisitions.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.